Cargando…
Landiolol: pharmacology and its use for rate control in atrial fibrillation in an emergency setting
This article provides new insight on landiolol, an ultra-short acting injectable betablocker, recently approved in Europe, with regard to its pharmacokinetic and pharmacodynamic profile, along with its first experience in Caucasian healthy volunteers and patients with atrial fibrillation. Landiolol...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909771/ https://www.ncbi.nlm.nih.gov/pubmed/30188959 http://dx.doi.org/10.1093/eurheartj/sux037 |